IL-18 Does not Increase Allergic Airway Disease in Mice When Produced by BCG. - Archive ouverte HAL Access content directly
Journal Articles Journal of Biomedicine and Biotechnology Year : 2007

IL-18 Does not Increase Allergic Airway Disease in Mice When Produced by BCG.

(1) , (2) , (1) , (3) , (4) , (1) , (1)
1
2
3
4

Abstract

Whilst BCG inhibits allergic airway responses in murine models, IL-18 has adversary effects depending on its environment. We therefore constructed a BCG strain producing murine IL-18 (BCG-IL-18) and evaluated its efficiency to prevent an asthma-like reaction in mice. BALB/cByJ mice were sensitized (day (D) 1 and D10) by intraperitoneal injection of ovalbumin (OVA)-alum and primary (D20-22) and secondary (D62, 63) challenged with OVA aerosols. BCG or BCG-IL-18 were intraperitonealy administered 1 hour before each immunization (D1 and D10). BCG-IL-18 and BCG were shown to similarly inhibit the development of AHR, mucus production, eosinophil influx, and local Th2 cytokine production in BAL, both after the primary and secondary challenge. These data show that IL-18 did not increase allergic airway responses in the context of the mycobacterial infection, and suggest that BCG-IL-18 and BCG are able to prevent the development of local Th2 responses and therefore inhibit allergen-induced airway responses even after restimulation.
Fichier principal
Vignette du fichier
Revised_Amniai.pdf (1.61 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-00305279 , version 1 (24-07-2008)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Latiffa Amniai, Franck Biet, Philippe Marquillies, Camille Locht, Joël Pestel, et al.. IL-18 Does not Increase Allergic Airway Disease in Mice When Produced by BCG.. Journal of Biomedicine and Biotechnology, 2007, 2007, pp.67276. ⟨10.1155/2007/67276⟩. ⟨inserm-00305279⟩
251 View
188 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More